Chengwei Li1, Brian G Gentry, John C Drach, Jiri Zemlicka. 1. Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201-1379, USA.
Abstract
Enantiomeric cyclopropavir phosphates (+)-9 and (-)-9 were synthesized and investigated as substrates for GMP kinase. N(2)-Isobutyryl-di-O-acetylcyclopropavir (11) was converted to (+)-monoacetate 12 using hydrolysis catalyzed by porcine liver esterase. Phosphorylation via phosphite 13 gave after deacylation, phosphate (+)-9. Acid-catalyzed tetrahydropyranylation of (+)-monoacetate 12 gave, after deacylation, tetrahydropyranyl derivative 14. Phosphorylation via phosphite 15 furnished, after deprotection, enantiomeric phosphate (-)-9. Racemic diphosphate 16 was also synthesized. The phosphate (+)-9 is a relatively good substrate for GMP kinase with a K(M) value of 57 microM that is similar to that of the natural substrates GMP (61 microM) and dGMP (82 microM). In contrast, the enantiomer (-)-9 is not a good substrate (K(M) 1200 microM) indicating a significant enantioselectivity for the GMP kinase catalyzed reaction of monophosphate to diphosphate.
Enantiomericcyclopropavir phosphates (+n class="Gene">)-9 and (-)-9 were synthesized and investigated as substrates for GMP kinase. N(2)-Isobutyryl-di-O-acetylcyclopropavir (11) was converted to (+)-monoacetate 12 using hydrolysis catalyzed by porcine liver esterase. Phosphorylation via phosphite 13 gave after deacylation, phosphate (+)-9. Acid-catalyzed tetrahydropyranylation of (+)-monoacetate 12 gave, after deacylation, tetrahydropyranyl derivative 14. Phosphorylation via phosphite 15 furnished, after deprotection, enantiomeric phosphate (-)-9. Racemic diphosphate 16 was also synthesized. The phosphate (+)-9 is a relatively good substrate for GMP kinase with a K(M) value of 57 microM that is similar to that of the natural substrates GMP (61 microM) and dGMP (82 microM). In contrast, the enantiomer (-)-9 is not a good substrate (K(M) 1200 microM) indicating a significant enantioselectivity for the GMP kinase catalyzed reaction of monophosphate to diphosphate.
Authors: Earl R Kern; Nicole L Kushner; Caroll B Hartline; Stephanie L Williams-Aziz; Emma A Harden; Shaoman Zhou; Jiri Zemlicka; Mark N Prichard Journal: Antimicrob Agents Chemother Date: 2005-03 Impact factor: 5.191
Authors: Y L Qiu; F Geiser; T Kira; E Gullen; Y C Cheng; R G Ptak; J M Breitenbach; J C Drach; C B Hartline; E R Kern; J Zemlicka Journal: Antivir Chem Chemother Date: 2000-05
Authors: Zhaohua Yan; Earl R Kern; Elizabeth Gullen; Yung-Chi Cheng; John C Drach; Jiri Zemlicka Journal: J Med Chem Date: 2005-01-13 Impact factor: 7.446
Authors: Y L Qiu; R G Ptak; J M Breitenbach; J S Lin; Y C Cheng; J C Drach; E R Kern; J Zemlicka Journal: Antiviral Res Date: 1999-08 Impact factor: 5.970
Authors: Shaoman Zhou; Julie M Breitenbach; Katherine Z Borysko; John C Drach; Earl R Kern; Elizabeth Gullen; Yung-Chi Cheng; Jiri Zemlicka Journal: J Med Chem Date: 2004-01-29 Impact factor: 7.446
Authors: Scott H James; Caroll B Hartline; Emma A Harden; Elizabeth M Driebe; James M Schupp; David M Engelthaler; Paul S Keim; Terry L Bowlin; Earl R Kern; Mark N Prichard Journal: Antimicrob Agents Chemother Date: 2011-07-25 Impact factor: 5.191
Authors: Han Chen; Chengwei Li; Jiri Zemlicka; Brian G Gentry; Terry L Bowlin; Donald M Coen Journal: Antimicrob Agents Chemother Date: 2016-06-20 Impact factor: 5.191
Authors: Karoly Toth; Islam T M Hussein; Ann E Tollefson; Baoling Ying; Jacqueline F Spencer; Jessica Eagar; Scott H James; Mark N Prichard; William S M Wold; Terry L Bowlin Journal: Antimicrob Agents Chemother Date: 2020-10-20 Impact factor: 5.191
Authors: Brian G Gentry; Jeremy P Kamil; Donald M Coen; Jiri Zemlicka; John C Drach Journal: Antimicrob Agents Chemother Date: 2010-06-14 Impact factor: 5.191
Authors: Nadine G Rouphael; Selwyn J Hurwitz; Mari Hart; Allison Beck; Evan J Anderson; Gregory Deye; Blaire Osborn; Shu Yi Cai; Chris Focht; Cyrille Amegashie; Terry L Bowlin; Jennifer Brooks; Mark J Mulligan Journal: Antimicrob Agents Chemother Date: 2019-08-23 Impact factor: 5.938